Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF, Romiti R.
An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890.
Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC.
Pediatr Clin North Am. 2018 Aug;65(4):757-781. doi: 10.1016/j.pcl.2018.04.002.
Localized scleroderma/morphea.
Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P.
Int J Dermatol. 2002 Aug;41(8):467-75. doi: 10.1046/j.1365-4362.2002.01469.x.
[Localized scleroderma (morphea)].
Bono W, Dupin N.
Presse Med. 2006 Dec;35(12 Pt 2):1923-8. doi: 10.1016/s0755-4982(06)74926-0.
Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review.
Hernandez A, Zapata Leiva L, Mutka M, Torok KS, Ledbetter L, Zigler CK.
Pediatr Rheumatol Online J. 2024 Aug 21;22(1):77. doi: 10.1186/s12969-024-01014-x.
Morphea (localized scleroderma).
Fett NM.
JAMA Dermatol. 2013 Sep;149(9):1124. doi: 10.1001/jamadermatol.2013.5079.
Upcoming treatments for morphea.
Wenzel D, Haddadi NS, Afshari K, Richmond JM, Rashighi M.
Immun Inflamm Dis. 2021 Dec;9(4):1101-1145. doi: 10.1002/iid3.475. Epub 2021 Jul 17.
Morphea and other localized forms of scleroderma.
Vasquez R, Sendejo C, Jacobe H.
Curr Opin Rheumatol. 2012 Nov;24(6):685-93. doi: 10.1097/BOR.0b013e32835896ce.
[Morphea or localized scleroderma and extragenital lichen sclerosus].
Moinzadeh P, Kreuter A, Krieg T, Hunzelmann N.
Hautarzt. 2018 Nov;69(11):892-900. doi: 10.1007/s00105-018-4266-7.
S2k guideline: Diagnosis and therapy of localized scleroderma.
Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN, Hammacher A, Krieg T, Wenzel J, Oeschger M, Weibel L, Müllegger R, Hunzelmann N.
J Dtsch Dermatol Ges. 2024 Apr;22(4):605-620. doi: 10.1111/ddg.15328. Epub 2024 Mar 1.
